Vivace® Direct – June 4th

Vivace® Direct – June 4, 2020


The old saying, “no pain, no gain”, previously had a place in the aesthetics industry. Today, however, the increasing demand for treatments, services and products has propelled advancements in the use of technology, pharmacology, and science, resulting in an enhanced overall patient experience.

Each patient’s journey is unique, and Aesthetics Biomedical is committed to growing the patient’s emotional investment, confidence, and comfort in aesthetic improvement through the Vivace Experience®.

The Vivace Experience® was designed to bring patients’ comfort to a new level. The Vivace®, a best-in-class RF microneedling treatment offers a precision robotic motor that is designed to minimize pain when compared to other similar devices. Many patients describe the feeling as light pressure on the face.


Your commitment to patient comfort should not be viewed as a luxury, but a necessity to achieve patient satisfaction without risking the desired results. This week, we will review strategies to maximize patient comfort and minimize fear or pain. These strategies are not only critical for patient satisfaction, but future visits. 

The table below outlines considerations for a patient centric strategic approach to maximize patient comfort.

Learn how to spot an anxious patient and talk to them. A well-informed patient is less likely to feel as anxious or stressed.  
Be descriptive of what to expect before, during and after treatment.  
Set appropriate expectations. Do not downplay discomfort but be intentional with your choice of words when describing potential patient experiences.  
Offer distractions for patients such as television screens or background music to be played if suitable. Patients appreciate the choice of selecting what to watch or music to hear.  
Always keep the lines of communication open. Inform them of an approaching sensitive treatment area or when the possibility of a fluctuation in comfort is expected. Frequently assess comfort levels.  
Finally, select an appropriate topical anesthetic and apply for the designated time to achieve maximum efficacy. This will assure proper “numbing” of the localized treatment area.  


Selecting the appropriate topical anesthetic agent is depended on several factors such as the amount of product used, concentration of active ingredients, method of application, physical location, size of the surface area, duration of product application and patient specific patient risk factors.

For the Vivace Experience®, it is recommended to use a light layer of Benzocaine / Lidocaine / Tetracaine combination (BLT 20/10/10), applied at least 20 to 30 minutes prior to treatment. Immediately prior to the start of the treatment, cleanse and wipe treated area with isopropyl alcohol. This step assures topical anesthetic has been removed off the skin. Unfortunately, there is not a “one size fits all” protocol. If your patient has a known allergy, or displays signs of reactivity, another topical anesthetic option should be considered and be available. Careful selection and application of topical anesthetics can greatly reduce pain during Vivace® treatments and enhance the overall Vivace Experience®.

We will see you next week as we discuss more clinical education updates and useful treatment techniques. Please feel free to send any questions or comments to

Disclaimer: The Vivace® Guidelines are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, medical director or qualified health provider with any questions you may have regarding a medical condition. All suggested treatment settings are for suggested use only.